A proprietary phytopharmaceutical formulation that activates systemic acquired resistance (SAR) in plants, providing broad-spectrum protection against pathogens and abiotic stresses. Validated through field trials showing 30% yield increase and 50% cost reduction compared to conventional treatments, with low toxicity profile.
This proprietary phytopharmaceutical formulation functions as a plant vaccine equivalent by activating Systemic Acquired Resistance (SAR), a salicylic acid-dependent immune response in plants. The product offers broad-spectrum, untargeted protection against a wide range of pathogens while simultaneously regulating the AsA-GSH pathway to defend against abiotic stresses. By stimulating the plant's natural defense mechanisms, the formulation increases production of antioxidant and defense enzymes and hormones, resulting in healthier crops and improved yields.
The solution addresses critical challenges in modern agriculture by providing a green, non-toxic alternative to traditional chemical pesticides. Applied through root drenching, it eliminates the need for hazardous spraying while delivering effective disease management. Field validation has demonstrated a 30% increase in yield and approximately 50% cost reduction compared to conventional treatments.
Mechanism of action:
Key features:
Validated applications:
The formulation has progressed through laboratory validation and field trials, with demonstrated efficacy against Phytophthora palmivora in arecanut, coconut, and pepper crops. The technology has been recognized by Indian government bodies and international institutions, including incubation by the National Research Development Corporation (NRDC) and recognition through Startup India.
Future validation efforts are focused on TR4 resistance in susceptible banana cultivars, with planned testing of enzyme and hormone activities followed by pathogen inoculation trials on promising leads. The company is actively seeking partnerships to support large-scale field trials, regulatory compliance, and commercialization efforts to bring this plant immunity solution to broader agricultural markets.
St. Jude Herbals Private Limited is an Indian agritech company based in Kasaragod, Kerala, founded in 2016. It specializes in developing and manufacturing plant-based agricultural solutions under its proprietary technology known as Plantopathy. Plantopathy acts as a green, non-toxic substitute for traditional chemical pesticides by utilizing systemic acquired resistance (SAR) to boost plant immune systems. Applied through root drenching, these products are designed to combat a wide spectrum of pathogens, enhance antioxidant enzyme production, and improve crop yields by up to 70%. The company’s manufacturing process focuses on sustainability and traceability, using phytopharmaceuticals extracted from plants grown by partner farmers.
The company serves B2B, B2C, and D2C markets, aiming to support farmers by offering a cost-effective, safer alternative to harmful chemical fungicides. By eliminating the need for hazardous spraying, the technology promotes environmental safety and protects the health of farmers and consumers. St. Jude Herbals has been recognized for its innovation by various Indian government bodies and international institutions, including incubation by the National Research Development Corporation (NRDC) and recognition through Startup India. Its research-driven approach seeks to foster sustainable agriculture and establish herbal care as a globally accessible standard for plant health.